Abstract
Background and Aims : Familial combined hyperlipidemia (FCH) is a frequent dyslipidemia often associated with metabolic syndrome (MetS). The magnitude of the atherosclerotic cardiovascular disease (ASCVD) risk increase in FCH is not clearly established. We used coronary artery calcium score (CAC) as a surrogate of the intensity of coronary atherosclerosis and as a strong predictor of MACE and compared its results in FCH versus T2D (type 2 diabetes) patients (a control group with a well-established high ASCVD risk).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
